7:02AM Auxilium Pharma beats by $0.12, reports revs in-line (AUXL) 17.22 : Reports Q3 (Sep) loss of $0.08 per share, $0.12 better than the Capital IQ Consensus Estimate of ($0.20); revenues rose 24.4% year/year to $66.7 mln vs the $66.8 mln consensus. As of September 30, 2011, co had $149.6 mln in cash and cash equivalents compared to $151.8 mln on June 30, 2011.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.